IVF Cost: China vs USA, UK & Thailand (2026)

IVF pricing is one of the clearest examples of how far medical costs diverge between countries for the same clinical procedure. The figures below are the indicative per-cycle ranges we use across our country comparisons, brought together in one place. None of them is a quote — a real plan always starts with a written, itemised estimate for your specific protocol.

Country Typical cost per standard IVF cycle (indicative) Notes
China US$6,000–10,000 at licensed reproductive centres; roughly US$7,000–13,000 at private international hospitals Concentrated in large public tertiary hospitals with high cycle volumes; strict eligibility rules apply (see below)
United States US$12,000–25,000 Before medication, which is commonly billed separately; multi-cycle packages raise the upfront figure further
United Kingdom £7,000–12,000 (private) NHS-funded cycles exist but with strict criteria and waiting lists that vary by region
Thailand US$12,000–18,000 Popular international-patient market with concierge-style private clinics priced accordingly
What "per cycle" usually covers — and what it does not. Base figures typically include monitoring, egg retrieval, standard fertilisation and one embryo transfer. Commonly billed on top, in every country: stimulation medication (highly variable by protocol and age), ICSI, preimplantation genetic testing, embryo freezing and storage, and later frozen-transfer cycles. This is why two "one-cycle" quotes can differ by thousands even inside the same clinic — compare itemised quotes, not headlines.

Why the China figure is lower

The gap is structural, not a discount. Chinese reproductive medicine runs through large public tertiary hospitals whose costs and prices operate under a regulated public system with very high patient volumes — the same mechanics that make Chinese hospital care broadly less expensive across imaging, screening and surgery. Assisted-reproduction licences are controlled, so treatment concentrates in a limited number of high-volume centres rather than fragmenting into boutique clinics with boutique pricing. The mainland's first IVF baby was born at Peking University Third Hospital in 1988; that centre alone now reports around 20,000 cycles a year.

The multi-cycle reality

Most patients do not budget for exactly one cycle. Because live-birth probability per cycle declines with age (national registries such as the US CDC and UK HFEA publish age-banded figures), a realistic financial plan often spans two or three cycles, including frozen transfers. At that point the per-cycle gap compounds: three cycles at US pricing can exceed the total cost of the same treatment plus travel and accommodation for two trips to China — though the honest arithmetic depends on your protocol, and travel adds real costs and logistics that a home-country clinic does not have.

Before you compare prices, check eligibility. Mainland China requires IVF patients to be married heterosexual couples with a marriage certificate; surrogacy is prohibited; and options for single women are heavily restricted. The full rules are at the top of our IVF in China guide for foreigners — read them first, because no price matters if the rules exclude you.

Where the comparison lands

China is the value option among serious IVF destinations for patients who meet its eligibility rules and are comfortable with a coordinated hospital experience rather than a boutique clinic one. The US buys convenience and the widest legal latitude at the highest price; the UK sits between, with NHS funding if you qualify; Thailand offers a polished international-patient experience at prices closer to Western than Chinese levels. For a couple who qualify and plan two trips, the arithmetic usually favours China well before the second cycle — but get every number in writing first, from any country you shortlist.

Want the China number for your specific situation — protocol, medication, testing and travel included, in writing?

Ask for an itemised estimate

Figures are indicative published ranges compiled for comparison, current as of 2026, and are not quotes or medical advice; actual costs depend on diagnosis, protocol and centre. Eligibility for treatment in mainland China is determined by licensed centres under Chinese regulations. SinoCareLink is a medical travel coordination service and is not a healthcare provider.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.